LEKPHARM QUALITY IS AFFORDABLE!
LEKPHARM is a full circle manufacturing pharmaceutical company that operates according to GMP standarts Developing Studies Registration Manufacturing Quality control Distribution
History In 2006 «Lekpharm» received license to perform pharmaceutical activities
History 2007 – GMP certificate for tablets manufacturing
History 2010 – renewal of GMP certificate for manufacturing tablets 2013 – renewal of GMP certificate for manufacturing tablets
History 2014 – international GMP certificate that complies Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S)
History 2015 – GMP certificate for manufacturing powders in sachet bags
History 2015 – GMP certificate for manufacturing sterile injections in ampoules
History 2011 – ISO 14001 certificate 2014 – ISO 14001 certificate renewal
История 2006 – laboratory accreditation under ISO 17025 2009, 2014 – ISO 17025 accreditation renewal
Awards « Best enterpreneur of Republic of Belarus » in medical field – 2009, 2010, 2011 Decree of the President of Republic of Belarus №296 от 01.07.2014 Lekpharm became a member of State Honor Board « Best export company of 2014 » in medical field
Manufacturing Forms: tablets capsules powders in sachets ampoules Cardiological medicines Medicines for treatment: Musculoskeletal system GIT General anesthesia Antiviral, symptomatic Mineral-vitamin complexes
Quality Main priority – guarantee the expected level and stability of the quality of products, its safety and efficiency.
Lekpharm – quality is affordable! Germany Austria Russia Denmark Great Britain Croatia China Czech Rep Spain India Latin America Careful selection of supply partners
Manufacturing Control over the proper operation of the equipment is carried out by highly qualified personnel Automatic control of production process parameters
Equipment Tablets Sachet bags Ampoules Capsules Contract Manufacturing Laboratory
Capacity The production capacity of the enterprise is 1 billion units per year for all forms combined
Manufacturing building Total area of the premises – 5582,9 m² Manufacturing area – 793,2 m² Warehouse area – 1600,6 m² Quality control department – 322,7 m² Chemical laboratory - 185,6 m² Microbiological laboratory - 137,1 m²
325 employees Departments: • Quality assesment – 5 • Quality control – 49 • Validation – 4 • Mechanics – 12 • Manufacturing – 111 • Research and Development – 21 • Warehouse – 7 • Distibution – 31 • Administration - 81
Key financial data 2016 Manufactured: 49,950 mln USD, growth rate 126,6% Supplied: 41,526 mln USD, growth rate 131,6% Exported: 5,653 mln USD
Lekpharm — one of the leading enterprises in Belarus № Company 2016 year Volume sales sum, USD 1 Belmedpreparaty 82 652 217 2 Borisovskiy Zavod Medicinskikh Preparatov 61 400 141 3 Lekpharm 42 856 058 4 NOVARTIS 29 208 750 5 Pharmland Group 25 669 972 6 SANOFI 25 540 888 7 TAKEDA 22 356 876 8 PHARMTECHNOLOGY 21 942 863 9 GEDEON RIHTER 20 778 128 10 GSK 20 592 574
Annual report Produced Produced Produced Produced Dosage form 2013 year 2014 year 2015 year 2016 year mln. Growth mln. Growth mln. Growth mln. Growth units rate % units rate % units rate % units rate % Tablets 473,1 119 546,4 115,5 606,3 130,0 519,9 85,7 Capsules 75,3 106 96,2 127,8 143,2 149,2 61,8 43,2 Sachet 5,5 440 8,7 157,9 14,9 171,3 12,1 6,7 Ampoules - - - - 0,2 - 1,9 950 Quality control studies: 2013 year – 81959 , 2014 year – 96629 , 2015 year – 126565, 2016 year – 137 748
The list of medicines 2007 2016 AMBROXOL ALFAHOLIN HYDROCHLOROTHIAZ CLOPIDOGREL LF MOXONIDIN LF TAMSULOSIN LF (choline IDE alfoscerate) AMLODIPINE AMBROXOL GLICLAZID MV LEVOCETIRIZIN LF MOLSIDOMIN LF TRI-ZIDIN M (trimetazidine) ARPETOL AMPLODIPINE GRIPOMIX LIZITAR LF NEIROVIT FENSPIRID LF (umifenovir) VIASIL AMLOTESIN DEZLORATADIN LF LIPROMAK LF NISIT FIGURIN (sildenafil) (perindopril/amlodip (ATORVASTATIN) (nimesulide) (orlistat) ine) VINNER LF ARPETOL DEXKETOPROFEN LF LOVASTATIN NITROGLYCERIN CHLOROPYRAMIN LF (vinpocetine) DROTAVERINE ASC DROTAVERINE MAGNELEK NIFUROXAZID LF HONDROMED (chondroitin sulfate) NITROGLYCERIN BETAHISTINUM INDALONG MEBEVERIN LF NITCERGOLIN LF HONDROMED PLUS (indapamide) (chondroitin sulfate+glucosamin) OMEPRAZOLE BICARD-LF INDATENSIN MEKSILEK OMEPRAZOLE CERALIN (bisoprolol) (perindopril/indapamid (citicoline) e) HONDROMED VIASIL INTRACONAZOL MELOXICAM LF ORVIKOLD EKVAPRIL (chondroitin sulfate) (sildenafil) ENALAPRIL VINNER LF KETONOF LF MELDONAT PERINDOPRIL LF ESFOLIP (vinpocetine) ABC of Health HEPATOLEK KETOPROFEN LF METOPROLOL RAMILONG RAMILONG PLUS (ramipril) (ramipril+hydrochlorothia zide) 11 INN 57 INN
We export in 7 countries | 28 Distributors | 87 foreign product registrations | Representative offices in Moldova, Kazakhstan Lithuania Russia Kazakhstan Ukraine Moldova Uzbekistan Kyrgyzstan Georgia Azerbaijan Vietnam
Expanding capacities in 2016 June 2015 Lekpharm started manufacturing of sterile injections in ampoules Innovative equipment and modern technology allow to reach capacity of 150 mln ampoules per year
Plans for 2017 In 2017 Lekpharm is going to modernize and increase capacity of manufacturing solid drug forms in tablets, capsules and powders
R&D of generics in 2017 R&D - 22 generics at BE stage – 10 medicines in the registration process – 7 medecines in the registration process abroad – 29 medicines in 2017-2018 R&D pipeline – more than 40 medicines
LEKPHARM JLLC Thank you for the attention! Belarus Logoisk, 2A Minskaya str. T: +375 25 606 90 12 email: office@Lekpharm.by marchenko@Lekpharm.by ostapchik@lekpharm.by
Recommend
More recommend
